In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113.
作者信息
Serbin Michael, Yonan Charles, Ganz Michael L
机构信息
Neurocrine Biosciences Inc., San Diego, CA, USA.
Real-world Evidence, Evidera, Waltham, MA, USA.
出版信息
J Med Econ. 2021 Jan-Dec;24(1):891-892. doi: 10.1080/13696998.2021.1948233.
Abstract
摘要
Zotero 插件